Review
doi: 10.3899/jrheum.091461.
Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities
Affiliations
- PMID: 20436161
- DOI: 10.3899/jrheum.091461
Item in Clipboard
Review
Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities
J Rheumatol Suppl.
2010 May.
Abstract
Immune-mediated inflammatory diseases (IMID) present a group of common and highly disabling chronic conditions that share inflammatory pathways. Several incidence and prevalence studies of IMID during the past decades have reported a considerable variation of the disease occurrence among different populations. Overall, the estimated prevalence of IMID in Western society is 5%-7%. This article provides an overview of studies of the incidence, prevalence, natural history, and comorbidities of IMID.
Similar articles
-
Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002.Curr Med Res Opin. 2006 May;22(5):989-1000. doi: 10.1185/030079906X104641. Curr Med Res Opin. 2006. PMID: 16709321
-
Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.Scand J Rheumatol. 2010;39(5):353-9. doi: 10.3109/03009741003674180. Scand J Rheumatol. 2010. PMID: 20615160
-
Pathophysiology and pathogenesis of immune-mediated inflammatory diseases: commonalities and differences.J Rheumatol Suppl. 2010 May;85:11-26. doi: 10.3899/jrheum.091462. J Rheumatol Suppl. 2010. PMID: 20436162 Review.
-
[Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].Herz. 2005 Sep;30(6):512-21. doi: 10.1007/s00059-005-2717-2. Herz. 2005. PMID: 16170682 Review. German.
-
Increased incidence of psychiatric disorders in immune-mediated inflammatory disease.J Psychosom Res. 2017 Oct;101:17-23. doi: 10.1016/j.jpsychores.2017.07.015. Epub 2017 Aug 1. J Psychosom Res. 2017. PMID: 28867419
Cited by
-
Contraceptive Recommendations for Women with Immune-Mediated Inflammatory Diseases: A Delphi Consensus.Adv Ther. 2024 Apr;41(4):1372-1384. doi: 10.1007/s12325-023-02779-5. Epub 2024 Feb 7. Adv Ther. 2024. PMID: 38326688
-
A multidisciplinary dermatology-gastroenterology-rheumatology (DER.RE.GA) unit for the care of patients with immune-mediated inflammatory diseases: analysis of the first 5 years from the dermatologist's perspective.Front Med (Lausanne). 2023 Nov 30;10:1290018. doi: 10.3389/fmed.2023.1290018. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38098849 Free PMC article.
-
Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition.Pharmacol Res Perspect. 2019 Nov 15;7(6):e00537. doi: 10.1002/prp2.537. eCollection 2019 Dec. Pharmacol Res Perspect. 2019. PMID: 31832202 Free PMC article.
-
No increased risk of Alzheimer's disease among people with immune-mediated inflammatory diseases: findings from a longitudinal cohort study of U.S. older adults.BMC Rheumatol. 2021 Nov 12;5(1):48. doi: 10.1186/s41927-021-00219-x. BMC Rheumatol. 2021. PMID: 34763722 Free PMC article.
-
Understanding anti-TNF treatment failure: does serum triiodothyronine-to-thyroxine (T3/T4) ratio predict therapeutic outcome to anti-TNF therapies in biologic-naïve patients with active luminal Crohn's disease?Aliment Pharmacol Ther. 2022 Sep;56(5):783-793. doi: 10.1111/apt.17089. Epub 2022 Jun 29. Aliment Pharmacol Ther. 2022. PMID: 35768996 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
